| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.0082 | 1 |